1. Sands J, Tammemagi MC, Couraud S, Baldwin DR, Borondy-Kitts A, Yankelevitz D, Lewis J, Grannis F, Kauczor HU, Von Stackelberg OJ. J. o. t. o. o. p. o. t. I. A. f. t. S. o. L. C., Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation. 2021, (1), 16.
2. Mariusz C, Jacek P, Beata J-P, Joanna R, Anna SCJO, Therapy. Quality of life of patients with lung cancer. 2016, 9, 1023–8.
3. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks J. D. J. N. E. J. M., Reduced lung-cancer mortality with low-dose computed tomographic screening. 2011, (5).
4. Wahidi MM, Govert JA, Goudar RK, Gould MK, Mccrory DCJC. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based Clinical Practice Guidelines (2nd Edition). 2007;132(3):94S–107S.
5. Michael K, Gould J, William D, Lynch R, Chest P. J. J., Evaluation of individuals with Pulmonary nodules: when is it Lung Cancer? Diagnosis and management of Lung Cancer. 3rd ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines; 2013.